Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration

Blood

Volumn 122, Issue 12, 2013, Pages 2125-2134

  Aoyama, Kazutoshi ^a   Saha, Asim ^a   Tolar, Jakub ^a   Riddle, Megan J ^a   Veenstra, Rachelle G ^a   Taylor, Patricia A ^a   Blomhoff, Rune ^b   Panoskaltsis Mortari, Angela ^a   Klebanoff, Christopher A ^c   Socíe, Ǵerard ^d   Munn, David H ^e   Murphy, William J ^f   Serody, Jonathan S ^g   Fulton, LeShara M ^g   Teshima, Takanori ^h   Chandraratna, Roshantha A ⁱ   Dmitrovsky, Ethan ^j   Guo, Yanxia ^k   Noelle, Randolph J ^k   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c NATIONAL CANCER INSTITUTE   (United States)

^d INSERM   (France)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ Therapeutics Inc   (United States)

^j Department of Pharmacology and Toxicology ^*  (Canada)

^k DARTMOUTH MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CHEMOKINE RECEPTOR CCR9; INTEGRIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOL; UNCLASSIFIED DRUG; HOMING RECEPTOR; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; IN VIVO STUDY; INTESTINE; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; ANIMAL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MORTALITY;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; GRAFT VS HOST DISEASE; INTESTINES; MICE; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TRETINOIN;

EID: 84885458195     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-11-470252     Document Type: Article

References (50)

1. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95(9):2754-2759.
2. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood. 1997;90(8):3204-3213.
3. Teshima T, Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575-581.
4. Takashima S, Kadowaki M, Aoyama K, et al. The Wnt agonist R-spondin1 regulates systemic graftversus- host disease by protecting intestinal stem cells. J Exp Med. 2011;208(2):285-294.
5. Socié G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327-4336.
6. Frota-Ruchon A, Marcinkiewicz M, Bhat PV. Localization of retinal dehydrogenase type 1 in the stomach and intestine. Cell Tissue Res. 2000; 302(3):397-400.
7. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints guthoming specificity on T cells. Immunity. 2004; 21(4):527-538.
8. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, et al. A functionally specialized population of mucosal CD1031 DCs induces Foxp31 regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007; 204(8):1757-1764.
9. Hammerschmidt SI, Ahrendt M, Bode U, et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med. 2008;205(11):2483-2490.
10. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317(5835):256-260.
11. Elias KM, Laurence A, Davidson TS, et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 2008;111(3):1013-1020.
12. Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-Alpha favours regulatory T cell induction at the expense of IL-17- secreting T helper cell differentiation. Eur J Immunol. 2007;37(9):2396-2399.
13. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996;10(9): 940-954.
14. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66(7): 606-630.
15. Nishimori H, Maeda Y, Teshima T, et al. Synthetic retinoid Am80 ameliorates chronic graft-versushost disease by down-regulating Th1 and Th17. Blood. 2012;119(1):285-295.
16. Koenecke C, Prinz I, Bubke A, et al. Shift of graftversus- host-disease target organ tropism by dietary vitamin A. PLoS ONE. 2012;7(5):e38252.
17. Wagner M. Detection and measurement of retinoic acid production by isolated tissues using retinoic acid-sensitive reporter cell lines. Methods Mol Biol. 1998;89:41-53.
18. Chen X, Dodge J, Komorowski R, Drobyski WR. A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graftversus- host disease. Blood. 2013;121(19): 3970-3980.
19. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 2007;204(8):1775-1785.
20. Molenaar R, Knippenberg M, Goverse G, et al. Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gutdraining lymph node stromal cells is controlled by dietary vitamin A. J Immunol. 2011;186(4): 1934-1942.
21. Guilliams M, Crozat K, Henri S, et al. Skindraining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(1) regulatory T cells. Blood. 2010;115(10): 1958-1968.
22. Svensson M, Johansson-Lindbom B, Zapata F, et al. Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD81 T cells. Mucosal Immunol. 2008;1(1):38-48.
23. Hall JA, Cannons JL, Grainger JR, et al. Essential role for retinoic acid in the promotion of CD4(1) T cell effector responses via retinoic acid receptor alpha. Immunity. 2011;34(3):435-447.
24. Guo Y, Pino-Lagos K, Ahonen CA, et al. A retinoic acid-rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(1) T cells. Cancer Res. 2012;72(20):5230-5239.
25. Rajaii F, Bitzer ZT, Xu Q, Sockanathan S. Expression of the dominant negative retinoid receptor, RAR403, alters telencephalic progenitor proliferation, survival, and cell fate specification. Dev Biol. 2008;316(2):371-382.
26. Pino-Lagos K, Guo Y, Brown C, et al. A retinoic acid-dependent checkpoint in the development of CD41 T cell-mediated immunity. J Exp Med. 2011;208(9):1767-1775.
27. Koyama M, Kuns RD, Olver SD, et al. Promoting regulation via the inhibition of DNAM-1 after transplantation. Blood. 2013;121(17):3511-3520.
28. Hernandez-Caselles T, Martinez-Esparza M, Lazarovits AI, Aparicio P. Specific regulation of VLA-4 and alpha 4 beta 7 integrin expression on human activated T lymphocytes. J Immunol. 1996;156(10):3668-3677.
29. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol. 2002;32(5): 1445-1454.
30. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-Trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med. 2007;204(8):1765-1774.
31. Bucher C, Koch L, Vogtenhuber C, et al. IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation. Blood. 2009;114(26):5375-5384.
32. Hsieh MH, Korngold R. Differential use of FasLand perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood. 2000;96(3): 1047-1055.
33. Schmaltz C, Alpdogan O, Muriglan SJ, et al. Donor T cell-derived TNF is required for graftversus- host disease and graft-versus-Tumor activity after bone marrow transplantation. Blood. 2003;101(6):2440-2445.
34. Kusmartsev S, Cheng F, Yu B, et al. All-Transretinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 2003;63(15):4441-4449.
35. Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 2010;116(25):5738-5747.
36. Petrovic A, Alpdogan O, Willis LM, et al. LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood. 2004;103(4):1542-1547.
37. Duffner U, Lu B, Hildebrandt GC, et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. 2003;31(10):897-902.
38. Hildebrandt GC, Corrion LA, Olkiewicz KM, et al. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol. 2004;173(3):2050-2059.
39. Papadakis KA, Prehn J, Nelson V, et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol. 2000;165(9):5069-5076.
40. Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature. 2003;424(6944):88-93.
41. Ferrara JL, Cooke KR, Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol. 2003;78(3):181-187.
42. Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest. 1998;102(12): 2126-2135.
43. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2, 3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood. 2009;114(24):5062-5070.
44. Murphy WJ, Welniak LA, Taub DD, et al. Differential effects of the absence of interferongamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest. 1998;102(9): 1742-1748.
45. Beres A, Komorowski R, Mihara M, Drobyski WR. Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Clin Cancer Res. 2011;17(12): 3969-3983.
46. Chen X, Das R, Komorowski R, et al. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graftversus- host disease. Blood. 2009;114(4): 891-900.
47. Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH. Vitamin A metabolites induce gut-homing FoxP31 regulatory T cells. J Immunol. 2007; 179(6):3724-3733.
48. Lee KA, Song YC, Kim GY, et al. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells. Eur J Immunol. 2012;42(7): 1685-1694.
49. Edinger M, Hoffmann P, Ermann J, et al. CD41 CD251 regulatory T cells preserve graft-versustumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9(9):1144-1150.
50. Pan L, Teshima T, Hill GR, et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versusleukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood. 1999;93(12):4071-4078.